Joanna Wiensch
Stock Analyst at Citigroup
(2.2)
# 965
Out of 5,344 analysts
31
Total ratings
73.68%
Success rate
20.57%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BDX Becton Dickinson | Downgrades: Neutral | 217 185 | 171.5 | 7.87% | 6 | May 22, 2025 | |
ABT Abbott Laboratories | Maintains: Strong Buy | 119 127 | 131.45 | -3.39% | 8 | Aug 22, 2024 | |
NVRO Nevro | Downgrades: Neutral | 40 | n/a | n/a | 1 | Jan 17, 2023 | |
DXCM DexCom | Maintains: Buy | 83 91 | 84.56 | 6.73% | 2 | Apr 29, 2020 | |
COO Cooper Companies | Maintains: Neutral | 90 80 | 78.89 | 0.77% | 2 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 142.78 | -15.95% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 200 | 268.72 | -25.57% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 40 | 96.2 | -58.42% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 168 | 92.75 | 81.13% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 63 | 86.54 | -27.2% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 235 | 376.8 | -37.63% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 220 | 321.32 | -31.53% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 84 | 75.03 | 11.96% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 94 | 30.16 | 211.67% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 163 | 153.06 | 6.49% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 124 | 80.68 | 53.69% | 1 | Mar 5, 2020 |